COVID-19 Outbreak-Global Nuclear Medicine-Radiopharmaceuticals Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

SKU ID :Maia-16013860 | Published Date: 04-Aug-2020 | No. of pages: 128
Table of Content 1 Nuclear Medicine-Radiopharmaceuticals Introduction and Market Overview 1.1 Objectives of the Study 1.2 Overview of Nuclear Medicine-Radiopharmaceuticals 1.3 Scope of The Study 1.3.1 Key Market Segments 1.3.2 Players Covered 1.3.3 COVID-19's impact on the Nuclear Medicine-Radiopharmaceuticals industry 1.4 Methodology of The Study 1.5 Research Data Source 2 Executive Summary 2.1 Market Overview 2.1.1 Global Nuclear Medicine-Radiopharmaceuticals Market Size, 2015 – 2020 2.1.2 Global Nuclear Medicine-Radiopharmaceuticals Market Size by Type, 2015 – 2020 2.1.3 Global Nuclear Medicine-Radiopharmaceuticals Market Size by Application, 2015 – 2020 2.1.4 Global Nuclear Medicine-Radiopharmaceuticals Market Size by Region, 2015 - 2025 2.2 Business Environment Analysis 2.2.1 Global COVID-19 Status and Economic Overview 2.2.2 Influence of COVID-19 Outbreak on Nuclear Medicine-Radiopharmaceuticals Industry Development 3 Industry Chain Analysis 3.1 Upstream Raw Material Suppliers of Nuclear Medicine-Radiopharmaceuticals Analysis 3.2 Major Players of Nuclear Medicine-Radiopharmaceuticals 3.3 Nuclear Medicine-Radiopharmaceuticals Manufacturing Cost Structure Analysis 3.3.1 Production Process Analysis 3.3.2 Manufacturing Cost Structure of Nuclear Medicine-Radiopharmaceuticals 3.3.3 Labor Cost of Nuclear Medicine-Radiopharmaceuticals 3.4 Market Distributors of Nuclear Medicine-Radiopharmaceuticals 3.5 Major Downstream Buyers of Nuclear Medicine-Radiopharmaceuticals Analysis 3.6 The Impact of Covid-19 From the Perspective of Industry Chain 3.7 Regional Import and Export Controls Will Exist for a Long Time 3.8 Continued downward PMI Spreads Globally 4 Global Nuclear Medicine-Radiopharmaceuticals Market, by Type 4.1 Global Nuclear Medicine-Radiopharmaceuticals Value and Market Share by Type (2015-2020) 4.2 Global Nuclear Medicine-Radiopharmaceuticals Production and Market Share by Type (2015-2020) 4.3 Global Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate by Type (2015-2020) 4.3.1 Global Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate of Diagnostic Medicine 4.3.2 Global Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate of Therapeutic Medicine 4.4 Global Nuclear Medicine-Radiopharmaceuticals Price Analysis by Type (2015-2020) 5 Nuclear Medicine-Radiopharmaceuticals Market, by Application 5.1 Downstream Market Overview 5.2 Global Nuclear Medicine-Radiopharmaceuticals Consumption and Market Share by Application (2015-2020) 5.3 Global Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate by Application (2015-2020) 5.3.1 Global Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate of SPECT (2015-2020) 5.3.2 Global Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate of PET (2015-2020) 5.3.3 Global Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate of Therapeutic (2015-2020) 6 Global Nuclear Medicine-Radiopharmaceuticals Market Analysis by Regions 6.1 Global Nuclear Medicine-Radiopharmaceuticals Sales, Revenue and Market Share by Regions 6.1.1 Global Nuclear Medicine-Radiopharmaceuticals Sales by Regions (2015-2020) 6.1.2 Global Nuclear Medicine-Radiopharmaceuticals Revenue by Regions (2015-2020) 6.2 North America Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) 6.3 Europe Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) 6.4 Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) 6.5 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) 6.6 South America Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) 7 North America Nuclear Medicine-Radiopharmaceuticals Market Analysis by Countries 7.1 The Influence of COVID-19 on North America Market 7.2 North America Nuclear Medicine-Radiopharmaceuticals Sales, Revenue and Market Share by Countries 7.2.1 North America Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020) 7.2.2 North America Nuclear Medicine-Radiopharmaceuticals Revenue by Countries (2015-2020) 7.3 United States Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) 7.4 Canada Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) 7.5 Mexico Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) 8 Europe Nuclear Medicine-Radiopharmaceuticals Market Analysis by Countries 8.1 The Influence of COVID-19 on Europe Market 8.2 Europe Nuclear Medicine-Radiopharmaceuticals Sales, Revenue and Market Share by Countries 8.2.1 Europe Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020) 8.2.2 Europe Nuclear Medicine-Radiopharmaceuticals Revenue by Countries (2015-2020) 8.3 Germany Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) 8.4 UK Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) 8.5 France Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) 8.6 Italy Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) 8.7 Spain Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) 8.8 Russia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) 9 Asia Pacific Nuclear Medicine-Radiopharmaceuticals Market Analysis by Countries 9.1 The Influence of COVID-19 on Asia Pacific Market 9.2 Asia Pacific Nuclear Medicine-Radiopharmaceuticals Sales, Revenue and Market Share by Countries 9.2.1 Asia Pacific Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020) 9.2.2 Asia Pacific Nuclear Medicine-Radiopharmaceuticals Revenue by Countries (2015-2020) 9.3 China Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) 9.4 Japan Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) 9.5 South Korea Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) 9.6 India Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) 9.7 Southeast Asia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) 9.8 Australia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) 10 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Market Analysis by Countries 10.1 The Influence of COVID-19 on Middle East and Africa Market 10.2 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Sales, Revenue and Market Share by Countries 10.2.1 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020) 10.2.2 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Revenue by Countries (2015-2020) 10.3 Saudi Arabia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) 10.4 UAE Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) 10.5 Egypt Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) 10.6 Nigeria Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) 10.7 South Africa Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) 11 South America Nuclear Medicine-Radiopharmaceuticals Market Analysis by Countries 11.1 The Influence of COVID-19 on Middle East and Africa Market 11.2 South America Nuclear Medicine-Radiopharmaceuticals Sales, Revenue and Market Share by Countries 11.2.1 South America Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020) 11.2.2 South America Nuclear Medicine-Radiopharmaceuticals Revenue by Countries (2015-2020) 11.3 Brazil Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) 11.4 Argentina Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) 11.5 Columbia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) 11.6 Chile Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) 12 Competitive Landscape 12.1 Immunomedics, Inc. (US) 12.1.1 Immunomedics, Inc. (US) Basic Information 12.1.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction 12.1.3 Immunomedics, Inc. (US) Production, Value, Price, Gross Margin 2015-2020 12.2 Lantheus Medical Imaging Inc (US) 12.2.1 Lantheus Medical Imaging Inc (US) Basic Information 12.2.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction 12.2.3 Lantheus Medical Imaging Inc (US) Production, Value, Price, Gross Margin 2015-2020 12.3 Triad Isotopes, Inc. (US) 12.3.1 Triad Isotopes, Inc. (US) Basic Information 12.3.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction 12.3.3 Triad Isotopes, Inc. (US) Production, Value, Price, Gross Margin 2015-2020 12.4 Advanced Medical Isotope Corporation (US) 12.4.1 Advanced Medical Isotope Corporation (US) Basic Information 12.4.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction 12.4.3 Advanced Medical Isotope Corporation (US) Production, Value, Price, Gross Margin 2015-2020 12.5 Nordion, Inc. (Canada) 12.5.1 Nordion, Inc. (Canada) Basic Information 12.5.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction 12.5.3 Nordion, Inc. (Canada) Production, Value, Price, Gross Margin 2015-2020 12.6 Medi-Radiopharma Ltd (Hungary) 12.6.1 Medi-Radiopharma Ltd (Hungary) Basic Information 12.6.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction 12.6.3 Medi-Radiopharma Ltd (Hungary) Production, Value, Price, Gross Margin 2015-2020 12.7 GE Healthcare (UK) 12.7.1 GE Healthcare (UK) Basic Information 12.7.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction 12.7.3 GE Healthcare (UK) Production, Value, Price, Gross Margin 2015-2020 12.8 Bracco Imaging S.p.A (Italy) 12.8.1 Bracco Imaging S.p.A (Italy) Basic Information 12.8.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction 12.8.3 Bracco Imaging S.p.A (Italy) Production, Value, Price, Gross Margin 2015-2020 12.9 Positron Corporation (US) 12.9.1 Positron Corporation (US) Basic Information 12.9.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction 12.9.3 Positron Corporation (US) Production, Value, Price, Gross Margin 2015-2020 12.10 Bayer HealthCare Medical Care (US) 12.10.1 Bayer HealthCare Medical Care (US) Basic Information 12.10.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction 12.10.3 Bayer HealthCare Medical Care (US) Production, Value, Price, Gross Margin 2015-2020 12.11 Cardinal Health, Inc (US) 12.11.1 Cardinal Health, Inc (US) Basic Information 12.11.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction 12.11.3 Cardinal Health, Inc (US) Production, Value, Price, Gross Margin 2015-2020 12.12 Mallinckrodt Pharmaceuticals (Ireland) 12.12.1 Mallinckrodt Pharmaceuticals (Ireland) Basic Information 12.12.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction 12.12.3 Mallinckrodt Pharmaceuticals (Ireland) Production, Value, Price, Gross Margin 2015-2020 12.13 Siemens Healthcare (US) 12.13.1 Siemens Healthcare (US) Basic Information 12.13.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction 12.13.3 Siemens Healthcare (US) Production, Value, Price, Gross Margin 2015-2020 12.14 Actinium Pharmaceuticals Inc (US) 12.14.1 Actinium Pharmaceuticals Inc (US) Basic Information 12.14.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction 12.14.3 Actinium Pharmaceuticals Inc (US) Production, Value, Price, Gross Margin 2015-2020 12.15 Alseres Pharmaceuticals, Inc (US) 12.15.1 Alseres Pharmaceuticals, Inc (US) Basic Information 12.15.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction 12.15.3 Alseres Pharmaceuticals, Inc (US) Production, Value, Price, Gross Margin 2015-2020 12.16 Jubilant Pharma (India) 12.16.1 Jubilant Pharma (India) Basic Information 12.16.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction 12.16.3 Jubilant Pharma (India) Production, Value, Price, Gross Margin 2015-2020 12.17 Avid Radiopharmaceuticals (US) 12.17.1 Avid Radiopharmaceuticals (US) Basic Information 12.17.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction 12.17.3 Avid Radiopharmaceuticals (US) Production, Value, Price, Gross Margin 2015-2020 12.18 Alliance Medical (UK) 12.18.1 Alliance Medical (UK) Basic Information 12.18.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction 12.18.3 Alliance Medical (UK) Production, Value, Price, Gross Margin 2015-2020 12.19 Ion Beam Applications S.A (Belgium) 12.19.1 Ion Beam Applications S.A (Belgium) Basic Information 12.19.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction 12.19.3 Ion Beam Applications S.A (Belgium) Production, Value, Price, Gross Margin 2015-2020 12.20 Peregrine Pharmaceuticals, Inc. (US) 12.20.1 Peregrine Pharmaceuticals, Inc. (US) Basic Information 12.20.2 Nuclear Medicine-Radiopharmaceuticals Product Introduction 12.20.3 Peregrine Pharmaceuticals, Inc. (US) Production, Value, Price, Gross Margin 2015-2020 13 Industry Outlook 13.1 Market Driver Analysis 13.1.2 Market Restraints Analysis 13.1.3 Market Trends Analysis 13.2 Merger, Acquisition and New Investment 13.3 News of Product Release 14 Global Nuclear Medicine-Radiopharmaceuticals Market Forecast 14.1 Global Nuclear Medicine-Radiopharmaceuticals Market Value & Volume Forecast, by Type (2020-2025) 14.1.1 Diagnostic Medicine Market Value and Volume Forecast (2020-2025) 14.1.2 Therapeutic Medicine Market Value and Volume Forecast (2020-2025) 14.2 Global Nuclear Medicine-Radiopharmaceuticals Market Value & Volume Forecast, by Application (2020-2025) 14.2.1 SPECT Market Value and Volume Forecast (2020-2025) 14.2.2 PET Market Value and Volume Forecast (2020-2025) 14.2.3 Therapeutic Market Value and Volume Forecast (2020-2025) 14.3 Nuclear Medicine-Radiopharmaceuticals Market Analysis and Forecast by Region 14.3.1 North America Market Value and Consumption Forecast (2020-2025) 14.3.2 Europe Market Value and Consumption Forecast (2020-2025) 14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025) 14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025) 14.3.5 South America Market Value and Consumption Forecast (2020-2025) 15 New Project Feasibility Analysis 15.1 Industry Barriers and New Entrants SWOT Analysis 15.1.1 Porter’s Five Forces Analysis 15.1.2 New Entrants SWOT Analysis 15.2 Analysis and Suggestions on New Project Investment  
List of Tables and Figures Figure Product Picture of Nuclear Medicine-Radiopharmaceuticals Table Product Specification of Nuclear Medicine-Radiopharmaceuticals Table Nuclear Medicine-Radiopharmaceuticals Key Market Segments Table Key Players Nuclear Medicine-Radiopharmaceuticals Covered Figure Global Nuclear Medicine-Radiopharmaceuticals Market Size, 2015 – 2025 Table Different Types of Nuclear Medicine-Radiopharmaceuticals Figure Global Nuclear Medicine-Radiopharmaceuticals Value ($) Segment by Type from 2015-2020 Figure Global Nuclear Medicine-Radiopharmaceuticals Market Share by Types in 2019 Table Different Applications of Nuclear Medicine-Radiopharmaceuticals Figure Global Nuclear Medicine-Radiopharmaceuticals Value ($) Segment by Applications from 2015-2020 Figure Global Nuclear Medicine-Radiopharmaceuticals Market Share by Applications in 2019 Figure Global Nuclear Medicine-Radiopharmaceuticals Market Share by Regions in 2019 Figure North America Nuclear Medicine-Radiopharmaceuticals Production Value ($) and Growth Rate (2015-2020) Figure Europe Nuclear Medicine-Radiopharmaceuticals Production Value ($) and Growth Rate (2015-2020) Figure Asia Pacific Nuclear Medicine-Radiopharmaceuticals Production Value ($) and Growth Rate (2015-2020) Figure Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Production Value ($) and Growth Rate (2015-2020) Figure South America Nuclear Medicine-Radiopharmaceuticals Production Value ($) and Growth Rate (2015-2020) Table Global COVID-19 Status and Economic Overview Figure Global COVID-19 Status Figure COVID-19 Comparison of Major Countries Figure Industry Chain Analysis of Nuclear Medicine-Radiopharmaceuticals Table Upstream Raw Material Suppliers of Nuclear Medicine-Radiopharmaceuticals with Contact Information Table Major Players Headquarters, and Service Area of Nuclear Medicine-Radiopharmaceuticals Figure Major Players Production Value Market Share of Nuclear Medicine-Radiopharmaceuticals in 2019 Table Major Players Nuclear Medicine-Radiopharmaceuticals Product Types in 2019 Figure Production Process of Nuclear Medicine-Radiopharmaceuticals Figure Manufacturing Cost Structure of Nuclear Medicine-Radiopharmaceuticals Figure Channel Status of Nuclear Medicine-Radiopharmaceuticals Table Major Distributors of Nuclear Medicine-Radiopharmaceuticals with Contact Information Table Major Downstream Buyers of Nuclear Medicine-Radiopharmaceuticals with Contact Information Table Global Nuclear Medicine-Radiopharmaceuticals Value ($) by Type (2015-2020) Table Global Nuclear Medicine-Radiopharmaceuticals Value Share by Type (2015-2020) Figure Global Nuclear Medicine-Radiopharmaceuticals Value Share by Type (2015-2020) Table Global Nuclear Medicine-Radiopharmaceuticals Production by Type (2015-2020) Table Global Nuclear Medicine-Radiopharmaceuticals Production Share by Type (2015-2020) Figure Global Nuclear Medicine-Radiopharmaceuticals Production Share by Type (2015-2020) Figure Global Nuclear Medicine-Radiopharmaceuticals Value ($) and Growth Rate of Diagnostic Medicine (2015-2020) Figure Global Nuclear Medicine-Radiopharmaceuticals Value ($) and Growth Rate of Therapeutic Medicine (2015-2020) Figure Global Nuclear Medicine-Radiopharmaceuticals Price by Type (2015-2020) Figure Downstream Market Overview Table Global Nuclear Medicine-Radiopharmaceuticals Consumption by Application (2015-2020) Table Global Nuclear Medicine-Radiopharmaceuticals Consumption Market Share by Application (2015-2020) Figure Global Nuclear Medicine-Radiopharmaceuticals Consumption Market Share by Application (2015-2020) Figure Global Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate of SPECT (2015-2020) Figure Global Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate of PET (2015-2020) Figure Global Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate of Therapeutic (2015-2020) Figure Global Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) Figure Global Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) and Growth (2015-2020) Table Global Nuclear Medicine-Radiopharmaceuticals Sales by Regions (2015-2020) Table Global Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Regions (2015-2020) Table Global Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) by Regions (2015-2020) Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Regions (2015-2020) Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Regions in 2015 Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Regions in 2019 Figure North America Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) Figure Europe Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) Figure Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) Figure Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) Figure South America Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) Figure North America COVID-19 Status Figure North America COVID-19 Confirmed Cases Major Distribution Figure North America Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) and Growth (2015-2020) Table North America Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020) Table North America Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Countries (2015-2020) Table North America Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) by Countries (2015-2020) Table North America Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Countries (2015-2020) Figure United States Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) Figure Canada Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) Figure Mexico Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020) Figure Europe COVID-19 Status Figure Europe COVID-19 Confirmed Cases Major Distribution Figure Europe Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) and Growth (2015-2020) Table Europe Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020) Table Europe Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Countries (2015-2020) Table Europe Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) by Countries (2015-2020) Table Europe Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Countries (2015-2020) Figure Germany Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) Figure UK Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) Figure France Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020) Figure Italy Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020) Figure Spain Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020) Figure Russia Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020) Figure Asia Pacific COVID-19 Status Figure Asia Pacific Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) and Growth (2015-2020) Table Asia Pacific Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020) Table Asia Pacific Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Countries (2015-2020) Table Asia Pacific Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) by Countries (2015-2020) Table Asia Pacific Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Countries (2015-2020) Figure China Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) Figure Japan Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) Figure South Korea Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020) Figure India Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020) Figure Southeast Asia Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020) Figure Australia Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020) Figure Middle East Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) and Growth (2015-2020) Table Middle East Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020) Table Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Countries (2015-2020) Table Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) by Countries (2015-2020) Table Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Countries (2015-2020) Figure Saudi Arabia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) Figure UAE Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) Figure Egypt Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020) Figure Nigeria Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020) Figure South Africa Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020) Figure South America Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) and Growth (2015-2020) Table South America Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020) Table South America Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Countries (2015-2020) Table South America Nuclear Medicine-Radiopharmaceuticals Revenue (M USD) by Countries (2015-2020) Table South America Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Countries (2015-2020) Figure Brazil Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) Figure Argentina Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020) Figure Columbia Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020) Figure Chile Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020) Figure Top 3 Market Share of Nuclear Medicine-Radiopharmaceuticals Companies in 2019 Figure Top 6 Market Share of Nuclear Medicine-Radiopharmaceuticals Companies in 2019 Table Major Players Production Value ($) Share (2015-2020) Table Immunomedics, Inc. (US) Profile Table Immunomedics, Inc. (US) Product Introduction Figure Immunomedics, Inc. (US) Production and Growth Rate Figure Immunomedics, Inc. (US) Value ($) Market Share 2015-2020 Table Lantheus Medical Imaging Inc (US) Profile Table Lantheus Medical Imaging Inc (US) Product Introduction Figure Lantheus Medical Imaging Inc (US) Production and Growth Rate Figure Lantheus Medical Imaging Inc (US) Value ($) Market Share 2015-2020 Table Triad Isotopes, Inc. (US) Profile Table Triad Isotopes, Inc. (US) Product Introduction Figure Triad Isotopes, Inc. (US) Production and Growth Rate Figure Triad Isotopes, Inc. (US) Value ($) Market Share 2015-2020 Table Advanced Medical Isotope Corporation (US) Profile Table Advanced Medical Isotope Corporation (US) Product Introduction Figure Advanced Medical Isotope Corporation (US) Production and Growth Rate Figure Advanced Medical Isotope Corporation (US) Value ($) Market Share 2015-2020 Table Nordion, Inc. (Canada) Profile Table Nordion, Inc. (Canada) Product Introduction Figure Nordion, Inc. (Canada) Production and Growth Rate Figure Nordion, Inc. (Canada) Value ($) Market Share 2015-2020 Table Medi-Radiopharma Ltd (Hungary) Profile Table Medi-Radiopharma Ltd (Hungary) Product Introduction Figure Medi-Radiopharma Ltd (Hungary) Production and Growth Rate Figure Medi-Radiopharma Ltd (Hungary) Value ($) Market Share 2015-2020 Table GE Healthcare (UK) Profile Table GE Healthcare (UK) Product Introduction Figure GE Healthcare (UK) Production and Growth Rate Figure GE Healthcare (UK) Value ($) Market Share 2015-2020 Table Bracco Imaging S.p.A (Italy) Profile Table Bracco Imaging S.p.A (Italy) Product Introduction Figure Bracco Imaging S.p.A (Italy) Production and Growth Rate Figure Bracco Imaging S.p.A (Italy) Value ($) Market Share 2015-2020 Table Positron Corporation (US) Profile Table Positron Corporation (US) Product Introduction Figure Positron Corporation (US) Production and Growth Rate Figure Positron Corporation (US) Value ($) Market Share 2015-2020 Table Bayer HealthCare Medical Care (US) Profile Table Bayer HealthCare Medical Care (US) Product Introduction Figure Bayer HealthCare Medical Care (US) Production and Growth Rate Figure Bayer HealthCare Medical Care (US) Value ($) Market Share 2015-2020 Table Cardinal Health, Inc (US) Profile Table Cardinal Health, Inc (US) Product Introduction Figure Cardinal Health, Inc (US) Production and Growth Rate Figure Cardinal Health, Inc (US) Value ($) Market Share 2015-2020 Table Mallinckrodt Pharmaceuticals (Ireland) Profile Table Mallinckrodt Pharmaceuticals (Ireland) Product Introduction Figure Mallinckrodt Pharmaceuticals (Ireland) Production and Growth Rate Figure Mallinckrodt Pharmaceuticals (Ireland) Value ($) Market Share 2015-2020 Table Siemens Healthcare (US) Profile Table Siemens Healthcare (US) Product Introduction Figure Siemens Healthcare (US) Production and Growth Rate Figure Siemens Healthcare (US) Value ($) Market Share 2015-2020 Table Actinium Pharmaceuticals Inc (US) Profile Table Actinium Pharmaceuticals Inc (US) Product Introduction Figure Actinium Pharmaceuticals Inc (US) Production and Growth Rate Figure Actinium Pharmaceuticals Inc (US) Value ($) Market Share 2015-2020 Table Alseres Pharmaceuticals, Inc (US) Profile Table Alseres Pharmaceuticals, Inc (US) Product Introduction Figure Alseres Pharmaceuticals, Inc (US) Production and Growth Rate Figure Alseres Pharmaceuticals, Inc (US) Value ($) Market Share 2015-2020 Table Jubilant Pharma (India) Profile Table Jubilant Pharma (India) Product Introduction Figure Jubilant Pharma (India) Production and Growth Rate Figure Jubilant Pharma (India) Value ($) Market Share 2015-2020 Table Avid Radiopharmaceuticals (US) Profile Table Avid Radiopharmaceuticals (US) Product Introduction Figure Avid Radiopharmaceuticals (US) Production and Growth Rate Figure Avid Radiopharmaceuticals (US) Value ($) Market Share 2015-2020 Table Alliance Medical (UK) Profile Table Alliance Medical (UK) Product Introduction Figure Alliance Medical (UK) Production and Growth Rate Figure Alliance Medical (UK) Value ($) Market Share 2015-2020 Table Ion Beam Applications S.A (Belgium) Profile Table Ion Beam Applications S.A (Belgium) Product Introduction Figure Ion Beam Applications S.A (Belgium) Production and Growth Rate Figure Ion Beam Applications S.A (Belgium) Value ($) Market Share 2015-2020 Table Peregrine Pharmaceuticals, Inc. (US) Profile Table Peregrine Pharmaceuticals, Inc. (US) Product Introduction Figure Peregrine Pharmaceuticals, Inc. (US) Production and Growth Rate Figure Peregrine Pharmaceuticals, Inc. (US) Value ($) Market Share 2015-2020 Table Market Driving Factors of Nuclear Medicine-Radiopharmaceuticals Table Merger, Acquisition and New Investment Table Global Nuclear Medicine-Radiopharmaceuticals Market Value ($) Forecast, by Type Table Global Nuclear Medicine-Radiopharmaceuticals Market Volume Forecast, by Type Figure Global Nuclear Medicine-Radiopharmaceuticals Market Value ($) and Growth Rate Forecast of Diagnostic Medicine (2020-2025) Figure Global Nuclear Medicine-Radiopharmaceuticals Market Volume ($) and Growth Rate Forecast of Diagnostic Medicine (2020-2025) Figure Global Nuclear Medicine-Radiopharmaceuticals Market Value ($) and Growth Rate Forecast of Therapeutic Medicine (2020-2025) Figure Global Nuclear Medicine-Radiopharmaceuticals Market Volume ($) and Growth Rate Forecast of Therapeutic Medicine (2020-2025) Table Global Market Value ($) Forecast by Application (2020-2025) Table Global Market Volume Forecast by Application (2020-2025) Figure Market Value ($) and Growth Rate Forecast of SPECT (2020-2025) Figure Market Volume and Growth Rate Forecast of SPECT (2020-2025) Figure Market Value ($) and Growth Rate Forecast of PET (2020-2025) Figure Market Volume and Growth Rate Forecast of PET (2020-2025) Figure Market Value ($) and Growth Rate Forecast of Therapeutic (2020-2025) Figure Market Volume and Growth Rate Forecast of Therapeutic (2020-2025) Figure North America Market Value ($) and Growth Rate Forecast (2020-2025) Figure North America Consumption and Growth Rate Forecast (2020-2025) Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025) Figure Europe Consumption and Growth Rate Forecast (2020-2025) Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025) Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025) Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025) Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025) Figure South America Market Value ($) and Growth Rate Forecast (2020-2025) Figure South America Consumption and Growth Rate Forecast (2020-2025) Figure Porter’s Five Forces Analysis Table New Entrants SWOT Analysis Table New Project Analysis of Investment Recovery
  • PRICE
  • $3660
    $7320
    $5000
    Buy Now

Our Clients